Balsalazide sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H13N3O6.2Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XL6BJI034, chemically known as benzoic acid, 5-((1e)-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt, dihydrate, but more generally known as balsalazide sodium, which bears US NIH Compound Identifier 6504526. European Medicines Agency schedules balsalazide sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06092MIG. Most nations, for tariff purposes, schedule balsalazide sodium under HS 29270000. SMILES: C1CC(CCC1C(=O)NCCC(=O)[O-])/N=N/C2CCC(C(C2)C(=O)[O-])O.O.O.[NA+].[NA+].